Alliances

Partly because the bidding for these contracts remain confidential, critics are questioning the secrecy and whether these deals actually are financially beneficial.

AbbVie will work to develop a cystic fibrosis transmembrane conductance regulator potentiator compound that it licensed from the Foundation.

The agreement revolves around the development and commercialization of Pliant’s preclinical candidate, PLN-1474, and up to three more integrin targets for liver fibrosis associated with nonalcoholic steatohepatitis.

Great Bay Bio is pleased to announce that a strategic cooperation was reached with Guangzhou Boji Medical Biotechnological Co., Ltd. to jointly develop GBB101, a new long-acting injectable biologics for the treatment of anemia caused by Chronic Kidney Disease A new joint venture company has been created to share the R&D achievements of the project, including intellectual property rights and any rights and interests arising in the R&D process.

Chief Executive Officer Scott Shively said the acquisition of an oral analgesic from Johnson & Johnson will be transformative for California-based Neumentum Inc.

National Nonprofit’s Enhanced Mobile App and Online Platform will Potentially Match Patients with Clinical Trials

ISCT announces it has formed a global consortium of a wide range of leading professional and education societies to combat the rise in the number of unproven commercial cell banking services.

Promore Pharma AB announced that the company has entered into an agreement with ABG Sundal Collier ASA whereby ABGSC will act as liquidity provider for the Promore Pharma share starting 21 October.

BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a collaboration with Blueprint Genetics, a leader in the field of clinical genetic testing, to develop new data driven services for hospitals and the life sciences industry.

The Center for Innovative Pharmacy Solutions at the University of Maryland School of Pharmacy is collaborating with emocha Mobile Health to expand the company’s clinician-led adherence solution offering.